← Leaderboards
Robert M. Friedlander
Brigham And Women'S Hospital
$14,236,800
Attributed
$15,338,296
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$15,338,296 · 7
By mechanism
R01$15,338,296 · 7
Top collaborators
- Marilyn Hravnak4 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Daniel Hal Solomon$26,002,677
- Julia Y. Wang$4,342,903
- Sue E Levkoff$5,292,528
- Akhilesh Pandey$12,726,065
- Marla J Berry$20,336,532
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisCessation Of LifeProteinsNeuronsPathway InteractionsBrainCellsCell DeathMutantCorpus Striatum StructureHuntington DiseaseAffectFunctional DisorderGenesEnzymesCaspaseMouse ModelCell LineMolecularSamplingEventNeuron LossNerve DegenerationDisease Progression
Grant awards (46)
Melatonin biosynthesis in neuronal mitochondria$377,038
R01 · FY2022 · NS · contact PI
Melatonin biosynthesis in neuronal mitochondria$386,046
R01 · FY2021 · NS · contact PI
Melatonin biosynthesis in neuronal mitochondria$394,411
R01 · FY2020 · NS · contact PI
Melatonin biosynthesis in neuronal mitochondria$399,519
R01 · FY2019 · NS · contact PI
Melatonin biosynthesis in neuronal mitochondria$399,519
R01 · FY2018 · NS · contact PI
Developing Goal Directed Perfusion Therapy in SAH Neurocardiac Injury$535,227
R01 · FY2017 · NR
Developing Goal Directed Perfusion Therapy in SAH Neurocardiac Injury$535,227
R01 · FY2016 · NR
Developing Goal Directed Perfusion Therapy in SAH Neurocardiac Injury$518,484
R01 · FY2015 · NR
Functional Role of Micro RNAs in Huntington's Disease Pathogenesis$378,682
R01 · FY2015 · NS · contact PI
Developing Goal Directed Perfusion Therapy in SAH Neurocardiac Injury$614,054
R01 · FY2014 · NR
Functional Role of Micro RNAs in Huntington's Disease Pathogenesis$374,894
R01 · FY2014 · NS · contact PI
Modulation of Caspase Pathways in Huntington's Disease$363,105
R01 · FY2014 · NS · contact PI
Modulation of Caspase Pathways in Huntington's Disease$393,998
R01 · FY2013 · NS · contact PI
Functional Role of Micro RNAs in Huntington's Disease Pathogenesis$390,521
R01 · FY2013 · NS · contact PI
Functional Role of Micro RNAs in Huntington's Disease Pathogenesis$417,559
R01 · FY2012 · NS · contact PI
Modulation of Caspase Pathways in Huntington's Disease$377,825
R01 · FY2012 · NS · contact PI
Modulation of Caspase Pathways in Huntington's Disease$361,914
R01 · FY2011 · NS · contact PI
Modulation of Caspase Pathways in Huntington's Disease$360,647
R01 · FY2010 · NS · contact PI
Dysregulation of MicroRNAs in Huntington's Disease$261,960
R01 · FY2010 · NS · contact PI
Identification of Novel Drugs that Counter Huntington's Disease$247,468
R01 · FY2010 · NS · contact PI
Dysregulation of MicroRNAs in Huntington's Disease$149,520
R01 · FY2010 · NS · contact PI
Identification of Novel Drugs that Counter Huntington's Disease$106,128
R01 · FY2010 · NS · contact PI
Dysregulation of MicroRNAs in Huntington's Disease$418,562
R01 · FY2009 · NS · contact PI
Modulation of caspase pathways in Huntington's Disease$391,508
R01 · FY2009 · NS · contact PI
Identification of Novel Drugs that Counter Huntington's Disease$370,225
R01 · FY2009 · NS · contact PI
Identification of Novel Drugs that Counter Huntington's Disease$132,000
R01 · FY2009 · NS · contact PI
Identification of Novel Drugs that Counter Huntington's Disease$71,977
R01 · FY2009 · NS · contact PI
Modulation of caspase pathways in Huntington's Disease$395,953
R01 · FY2008 · NS · contact PI
Identification of Novel Drugs that Counter Huntington's Disease$356,928
R01 · FY2008 · NS · contact PI
Modulation of caspase pathways in Huntington's Disease$417,598
R01 · FY2007 · NS · contact PI
Identification of Novel Drugs that Counter Huntington's Disease$358,897
R01 · FY2007 · NS · contact PI
Modulation of caspase pathways in Huntington's Disease$388,436
R01 · FY2006 · NS · contact PI
Identification of Novel Drugs that Counter Huntington's Disease$366,336
R01 · FY2006 · NS · contact PI
Modulation of caspase pathways in Huntington's Disease$406,442
R01 · FY2005 · NS
Mechanisms and modulation of disease progression in ALS$321,030
R01 · FY2005 · NS
MODULATION OF CASPASE PATHWAYS IN HUNTINGTON'S DISEASE$320,899
R01 · FY2004 · NS
Mechanisms and modulation of disease progression in ALS$315,748
R01 · FY2004 · NS
Mechanisms and modulation of disease progression in ALS$315,087
R01 · FY2003 · NS
MODULATION OF CASPASE PATHWAYS IN HUNTINGTON'S DISEASE$311,553
R01 · FY2003 · NS
Mechanisms and modulation of disease progression in ALS$72,585
R01 · FY2003 · NS
MODULATION OF CASPASE PATHWAYS IN HUNTINGTON'S DISEASE$38,659
R01 · FY2003 · NS
MODULATION OF CASPASE PATHWAYS IN HUNTINGTON'S DISEASE$302,480
R01 · FY2002 · NS
Mechanisms and modulation of disease progression in ALS$291,337
R01 · FY2002 · NS
MODULATION OF CASPASE PATHWAYS IN HUNTINGTON'S DISEASE$293,669
R01 · FY2001 · NS
MODULATION OF CASPASE PATHWAYS IN HUNTINGTON'S DISEASE$50,000
R01 · FY2001 · NS
MODULATION OF CASPASE PATHWAYS IN HUNTINGTON'S DISEASE$286,641
R01 · FY2000 · NS